{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T10:37:09Z","timestamp":1775299029642,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T00:00:00Z","timestamp":1281916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2210-10-9","type":"journal-article","created":{"date-parts":[[2010,8,17]],"date-time":"2010-08-17T06:15:13Z","timestamp":1282025713000},"source":"Crossref","is-referenced-by-count":13,"title":["Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) Receptor Antagonist"],"prefix":"10.1186","volume":"10","author":[{"given":"John R","family":"Hadcock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A","family":"Carpino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A","family":"Iredale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L","family":"Dow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Gautreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucinda","family":"Thiede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Kelly-Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S","family":"Lizano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Van Deusen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen M","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca E","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn C","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis O","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,16]]},"reference":[{"issue":"2","key":"722_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, Cabral , Casellas G, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG: International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors. Pharmacol Rev. 2002, 54 (2): 161-202. 10.1124\/pr.54.2.161.","journal-title":"Pharmacol Rev"},{"key":"722_CR2","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1997","unstructured":"Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC). 1997, 258: 1946-1949. 10.1126\/science.1470919.","journal-title":"Science (Wash DC)"},{"issue":"1","key":"722_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z: Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol. 1995, 50 (1): 83-90. 10.1016\/0006-2952(95)00109-D.","journal-title":"Biochem Pharmacol"},{"key":"722_CR4","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1073\/pnas.061029898","volume":"98","author":"L Hanus","year":"2001","unstructured":"Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I, Mechoulam R: 2-arachindoyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci USA. 2001, 98: 3662-3665. 10.1073\/pnas.061029898.","journal-title":"Proc Natl Acad Sci USA"},{"key":"722_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3565(25)22356-4","volume":"270","author":"PB Smith","year":"1994","unstructured":"Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR: The pharmacological activity of anandamide, a putative endogenous cannabinoid. J Pharmacol Exp Therap. 1994, 270: 219-27.","journal-title":"J Pharmacol Exp Therap"},{"issue":"1","key":"722_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s002130050326","volume":"132","author":"M Arnone","year":"1997","unstructured":"Arnone M, Maruani J, Chaperon F, Thiebot M-H, Poncelet M, Soubrie P, Le Fur G: Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology. 1997, 132 (1): 104-106. 10.1007\/s002130050326.","journal-title":"Psychopharmacology"},{"issue":"6830","key":"722_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/35071088","volume":"410","author":"V Di Marzo","year":"2001","unstructured":"Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura G, Palmiter RD, Sugiura T, Kunos G: Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature. 2001, 410 (6830): 822-825. 10.1038\/35071088.","journal-title":"Nature"},{"issue":"6","key":"722_CR8","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1210\/en.2009-0046","volume":"50","author":"AD de Kloet","year":"2009","unstructured":"de Kloet AD, Woods SC: Minireview: Endocannabinoids and Their Receptors as Targets for Obesity Therapy. Endocrinol. 2009, 50 (6): 2531-2536. 10.1210\/en.2009-0046.","journal-title":"Endocrinol"},{"issue":"48","key":"722_CR9","doi-asserted-by":"publisher","first-page":"33021","DOI":"10.1074\/jbc.R800012200","volume":"283","author":"G Kunos","year":"2008","unstructured":"Kunos G, Osei-Hyiaman D, Liu J, Godlewski G, Batkai S: Endocannabinoids and the Control of Energy Homeostasis. J Biol Chem. 2008, 283 (48): 33021-33025. 10.1074\/jbc.R800012200.","journal-title":"J Biol Chem"},{"key":"722_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1210\/er.2005-0009","volume":"27","author":"U Pagotto","year":"2006","unstructured":"Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R: The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev. 2006, 27: 73-100. 10.1210\/er.2005-0009.","journal-title":"Endocr Rev"},{"key":"722_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","volume":"350","author":"M Rinaldi-Carmona","year":"1994","unstructured":"Rinaldi-Carmona M, Barth F, H\u00e9aulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, N\u00e9liat G, Caput D, Ferrara P, Soubri\u00e9 P, Breli\u00e8re JC, Le Fur G: SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 1994, 350: 240-244. 10.1016\/0014-5793(94)00773-X.","journal-title":"FEBS Lett"},{"key":"722_CR12","doi-asserted-by":"publisher","first-page":"7584","DOI":"10.1021\/jm060996+","volume":"49","author":"LS Lin","year":"2006","unstructured":"Lin LS, Lanza TJ, Jewell JP, Liu P, Shah SK, Qi H, Tong X, Wang J, Xu SS, Fong TM, Shen CP, Lao J, Xiao JC, Shearman LP, Stribling DS, Rosko K, Strack A, Marsh DJ, Feng Y, Kumar S, Samuel K, Yin W, Van der Ploeg LH, Goulet MT, Hagmann WK: Discovery of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesity. J Med Chem. 2006, 49: 7584-7587. 10.1021\/jm060996+.","journal-title":"J Med Chem"},{"key":"722_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1021\/jm8012932","volume":"52","author":"DA Griffith","year":"2009","unstructured":"Griffith DA, Hadcock JR, Black SC, Iredale PA, Carpino PA, DaSilva-Jardine P, Day R, DiBrino J, Dow RL, Landis MS, O'Connor RE, Scott DO: Discovery of 1-[9-(4-Chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-Yl]-4-ethylaminopiperidine-4-carboxylic Acid Amine Hydrochloride (CP-945,598), a Novel, Potent and Selective Cannabinoid CB1 Receptor Antagonist. J Med Chem. 2009, 52: 234-237. 10.1021\/jm8012932.","journal-title":"J Med Chem"},{"issue":"1","key":"722_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1124\/jpet.107.125666","volume":"323","author":"X Cao","year":"2007","unstructured":"Cao X, Liang L, Hadcock JR, Iredale PA, Griffith DA, Menniti FS, Factor S, Greenamyre JT, Papa SM: Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys. J Pharmacol Exp Ther. 2007, 323 (1): 318-326. 10.1124\/jpet.107.125666.","journal-title":"J Pharmacol Exp Ther"},{"issue":"16","key":"722_CR15","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1016\/j.tet.2008.10.067","volume":"65","author":"TA Brandt","year":"2009","unstructured":"Brandt TA, Caron S, Damon DB, DiBrino J, Ghosh A, Griffith DA, Kedia S, Ragan JA, Rose PR, Vanderplas BC, Wei L: Development of two synthetic routes to CE-178253, a CB1 antagonist for the treatment of obesity. Tetrahedron. 2009, 65 (16): 3292-3304. 10.1016\/j.tet.2008.10.067.","journal-title":"Tetrahedron"},{"key":"722_CR16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0026-895X(25)09370-8","volume":"50","author":"R Bass","year":"1996","unstructured":"Bass R, Strnad J, Price LA, Pausch MH, Hadcock JR: Identification and characterization of novel somatostatin antagonists. Mol Pharm. 1996, 50: 709-715.","journal-title":"Mol Pharm"},{"issue":"1","key":"722_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1124\/dmd.104.001222","volume":"33","author":"TS Maurer","year":"2005","unstructured":"Maurer TS, Debartolo DB, Tess DA, Scott DO: Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice. Drug metabolism and disposition: the biological fate of chemicals. 2005, 33 (1): 175-81. 10.1124\/dmd.104.001222.","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"key":"722_CR18","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/S0014-2999(97)01160-6","volume":"334","author":"RS Landsman","year":"1997","unstructured":"Landsman RS, Burkey TH, Consroe P, Roeske WR, Yamamura HI: SR-141716 is an inverse agonist at the human cannabinoid CB1 receptor. Eur J Pharmacol. 1997, 334: R1-R2. 10.1016\/S0014-2999(97)01160-6.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"722_CR19","first-page":"156","volume":"30","author":"RA Roth","year":"2005","unstructured":"Roth RA: The enigmatic pharmacology of GPR55. Trends Pharmacol Sci. 2005, 30 (3): 156-163.","journal-title":"Trends Pharmacol Sci"},{"issue":"16","key":"722_CR20","doi-asserted-by":"publisher","first-page":"12856","DOI":"10.1074\/jbc.M008555200","volume":"276","author":"L De Petrocellis","year":"2001","unstructured":"De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, Di Marzo V: The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem. 2001, 276 (16): 12856-63. 10.1074\/jbc.M008555200.","journal-title":"J Biol Chem"},{"issue":"9","key":"722_CR21","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.yexcr.2007.01.008","volume":"313","author":"L De Petrocellis","year":"2007","unstructured":"De Petrocellis L, Starowicz K, Moriello AS, Vivese MM, Orlando P, Di Marzo V: Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids. Experimental Cell Research. 2007, 313 (9): 1911-20. 10.1016\/j.yexcr.2007.01.008.","journal-title":"Experimental Cell Research"},{"issue":"8","key":"722_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/bdd.325","volume":"23","author":"JC Kalvass","year":"2002","unstructured":"Kalvass JC, Maurer SM: Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery. Biopharmaceutics & Drug Disposition. 2002, 23 (8): 327-338.","journal-title":"Biopharmaceutics & Drug Disposition"},{"key":"722_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1124\/dmd.104.001222","volume":"33","author":"TS Maurer","year":"2005","unstructured":"Maurer TS, DeBartolo DB, Tess DA, Scott DO: Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice. Drug Metab Dispos. 2005, 33: 175-81. 10.1124\/dmd.104.001222.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"722_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1517\/17425250903559873","volume":"6","author":"KD Read","year":"2010","unstructured":"Read KD, Braggio S: Assessing brain free fraction in early drug discovery. Expert Opinion on Drug Metabolism & Toxicology. 2010, 6 (3): 337-344.","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"722_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00008877-200509000-00004","volume":"16","author":"TC Kirkham","year":"2005","unstructured":"Kirkham TC: Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol. 2005, 16: 297-313. 10.1097\/00008877-200509000-00004.","journal-title":"Behav Pharmacol"},{"key":"722_CR26","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1210\/jc.2005-2679","volume":"91","author":"I Matias","year":"2006","unstructured":"Matias I, Gonthier MP, Orlando P, Martiadis V, De Petrocellis L, Cervino C, Petrosino S, Hoareau L, Festy F, Pasquali R, Roche R, Maj M, Pagotto U, Monteleone P, Di Marzo V: Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab. 2006, 91: 3171-3180. 10.1210\/jc.2005-2679.","journal-title":"J Clin Endocrinol Metab"},{"key":"722_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/jama.295.7.761","volume":"295","author":"FX Pi-Sunyer","year":"2006","unstructured":"Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J: Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA. 2006, 295: 761-775. 10.1001\/jama.295.7.761.","journal-title":"JAMA"},{"key":"722_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","volume":"136","author":"TC Kirkham","year":"2002","unstructured":"Kirkham TC, Williams CM, Fezza F, Di Marzo V: Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol. 2002, 136: 550-557. 10.1038\/sj.bjp.0704767.","journal-title":"Br J Pharmacol"},{"issue":"8","key":"722_CR29","doi-asserted-by":"publisher","first-page":"PL113","DOI":"10.1016\/S0024-3205(98)00322-1","volume":"63","author":"G Colombo","year":"1998","unstructured":"Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL: Appetite suppression and weight loss after the cannabinoid antagonist SR141716. Life Sci. 1998, 63 (8): PL113-PL117. 10.1016\/S0024-3205(98)00322-1.","journal-title":"Life Sci"},{"issue":"2","key":"722_CR30","doi-asserted-by":"publisher","first-page":"R345","DOI":"10.1152\/ajpregu.00545.2002","volume":"284","author":"C Trillou Ravinet","year":"2003","unstructured":"Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N: Keane, Peter, Maffrand, J-P, Soubrie, Philippe. Anti-obesity effect of SR-141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol. 2003, 284 (2): R345-353.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"722_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-002-1384-8","volume":"167","author":"SP Vickers","year":"2003","unstructured":"Vickers SP, Webster LJ, Wyatt A, Dourish CT, Kennett GA: Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa\/fa) compared to lean Zucker rats. Psychopharmacology. 2003, 167 (1): 103-111.","journal-title":"Psychopharmacology"},{"issue":"1-3","key":"722_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0014-2999(03)01343-8","volume":"462","author":"AL Hildebrandt","year":"2003","unstructured":"Hildebrandt AL, Kelly-Sullivan DM, Black SC: Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol. 2003, 462 (1-3): 125-132. 10.1016\/S0014-2999(03)01343-8.","journal-title":"Eur J Pharmacol"},{"key":"722_CR33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1124\/jpet.106.118737","volume":"321","author":"TM Fong","year":"2007","unstructured":"Fong TM, Guan X-M, Marsh DJ, Shen CP, Stribling DS, Rosko KM, Lao J, Yu H, Feng Y, Xiao JC, Van der Ploeg LHT, Goulet MK, Hagmann WK, Lin LS, Lanza TJ, Jewell JP, Liu P, Shah SK, Qi H, Tong X, Wang J, Xu SS, Francis B, Strack AM, MacIntyre DE: Shearman, LP.Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents. J.Pharmacol Exp Ther. 2007, 321: 1013-1022. 10.1124\/jpet.106.118737.","journal-title":"J.Pharmacol Exp Ther"},{"issue":"1","key":"722_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tips.2008.10.001","volume":"30","author":"G Kunos","year":"2009","unstructured":"Kunos G, Osei-Hyiaman D, B\u00e1tkai S, Sharkey KA, Makriyannis A: Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?. Trends Pharmacol Sci. 2009, 30 (1): 1-7. 10.1016\/j.tips.2008.10.001.","journal-title":"Trends Pharmacol Sci"},{"key":"722_CR35","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.2337\/db08-0161","volume":"57","author":"R Nogueiras","year":"2008","unstructured":"Nogueiras R, Veyrat-Durebex C, Suchanek PM, Klein M, Tsch\u00f6p J, Caldwell C, Woods SC, Wittmann G, Watanabe M, Liposits Z, Fekete C, Reizes O, Rohner-Jeanrenaud F, Tsch\u00f6p MH: Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats. Diabetes. 2008, 57: 2977-2991. 10.2337\/db08-0161.","journal-title":"Diabetes"}],"container-title":["BMC Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2210-10-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2210-10-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2210-10-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T18:13:17Z","timestamp":1740420797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1186\/1471-2210-10-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,16]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["722"],"URL":"https:\/\/doi.org\/10.1186\/1471-2210-10-9","relation":{},"ISSN":["1471-2210"],"issn-type":[{"value":"1471-2210","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,16]]},"article-number":"9"}}